328 related articles for article (PubMed ID: 17906158)
1. Optimal adaptive design in clinical drug development: a simulation example.
Maloney A; Karlsson MO; Simonsson US
J Clin Pharmacol; 2007 Oct; 47(10):1231-43. PubMed ID: 17906158
[TBL] [Abstract][Full Text] [Related]
2. Adaptive designs for confirmatory clinical trials.
Bretz F; Koenig F; Brannath W; Glimm E; Posch M
Stat Med; 2009 Apr; 28(8):1181-217. PubMed ID: 19206095
[TBL] [Abstract][Full Text] [Related]
3. A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials.
Hall DB; Meier U; Diener HC
Contemp Clin Trials; 2005 Jun; 26(3):349-64. PubMed ID: 15911469
[TBL] [Abstract][Full Text] [Related]
4. Adaptive two-stage designs in phase II clinical trials.
Banerjee A; Tsiatis AA
Stat Med; 2006 Oct; 25(19):3382-95. PubMed ID: 16479547
[TBL] [Abstract][Full Text] [Related]
5. Optimal and minimax three-stage designs for phase II oncology clinical trials.
Chen K; Shan M
Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
[TBL] [Abstract][Full Text] [Related]
6. Adaptive designs for dose-finding in non-cancer phase II trials: influence of early unexpected outcomes.
Resche-Rigon M; Zohar S; Chevret S
Clin Trials; 2008; 5(6):595-606. PubMed ID: 19029208
[TBL] [Abstract][Full Text] [Related]
7. An adaptive dose-finding design incorporating both toxicity and efficacy.
Zhang W; Sargent DJ; Mandrekar S
Stat Med; 2006 Jul; 25(14):2365-83. PubMed ID: 16220478
[TBL] [Abstract][Full Text] [Related]
8. Optimal designs for estimating the most successful dose.
Zohar S; O'Quigley J
Stat Med; 2006 Dec; 25(24):4311-20. PubMed ID: 16969893
[TBL] [Abstract][Full Text] [Related]
9. Bayesian optimal designs for a quantal dose-response study with potentially missing observations.
Baek I; Zhu W; Wu X; Wong WK
J Biopharm Stat; 2006; 16(5):679-93. PubMed ID: 17037265
[TBL] [Abstract][Full Text] [Related]
10. A Bayesian design and analysis for dose-response using informative prior information.
Smith MK; Marshall S
J Biopharm Stat; 2006; 16(5):695-709. PubMed ID: 17037266
[TBL] [Abstract][Full Text] [Related]
11. An improved method of evaluating drug effect in a multiple dose clinical trial.
Shen L
Stat Med; 2001 Jul; 20(13):1913-29. PubMed ID: 11427949
[TBL] [Abstract][Full Text] [Related]
12. Optimal dose-finding designs with correlated continuous and discrete responses.
Fedorov V; Wu Y; Zhang R
Stat Med; 2012 Feb; 31(3):217-34. PubMed ID: 22162014
[TBL] [Abstract][Full Text] [Related]
13. Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests.
Polley MY; Cheung YK
Biometrics; 2008 Mar; 64(1):232-41. PubMed ID: 17573866
[TBL] [Abstract][Full Text] [Related]
14. Multiple-objective designs in a dose-response experiment.
Zhu W; Wong WK
J Biopharm Stat; 2000 Feb; 10(1):1-14. PubMed ID: 10709797
[TBL] [Abstract][Full Text] [Related]
15. Predicting the outcome of phase III trials using phase II data: a case study of clinical trial simulation in late stage drug development.
De Ridder F
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):235-41. PubMed ID: 15733220
[TBL] [Abstract][Full Text] [Related]
16. A Bayesian adaptive design for multi-dose, randomized, placebo-controlled phase I/II trials.
Xie F; Ji Y; Tremmel L
Contemp Clin Trials; 2012 Jul; 33(4):739-48. PubMed ID: 22426247
[TBL] [Abstract][Full Text] [Related]
17. Improved up-and-down designs for phase I trials.
Ivanova A; Montazer-Haghighi A; Mohanty SG; Durham SD
Stat Med; 2003 Jan; 22(1):69-82. PubMed ID: 12486752
[TBL] [Abstract][Full Text] [Related]
18. Regulatory perspectives on multiplicity in adaptive design clinical trials throughout a drug development program.
Wang SJ; Hung HM; O'Neill R
J Biopharm Stat; 2011 Jul; 21(4):846-59. PubMed ID: 21516573
[TBL] [Abstract][Full Text] [Related]
19. ISCTM: Implementing phase 2 dose finding adaptive clinical trials.
Parke T
Eur Neuropsychopharmacol; 2011 Feb; 21(2):167-74. PubMed ID: 20947316
[TBL] [Abstract][Full Text] [Related]
20. Optimal phase I dose-escalation trial designs in oncology--a simulation study.
Gerke O; Siedentop H
Stat Med; 2008 Nov; 27(26):5329-44. PubMed ID: 17849502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]